Title
Author
DOI
Article Type
Special Issue
Volume
Issue
The role of leptin in breast cancer
1Department Perinatology, University of Medical Sciences in Poznan, Poland
*Corresponding Author(s): A. Markowska E-mail:
Leptin, the protein hormone produced mainly by adipocytes, placenta and mammary epithelium plays a significant role in, e.g., control of metabolism, reproductive processes, immune processes, angiogenesis, haemopoiesis and oxidation of lipids. Since some authors link leptin to mechanisms of mammary cancer development, the clinical data has been screened to allow evaluation of the hypothesis.
Leptin; Breast cancer
A. Markowska,K. Malendowicz,K. Drews. The role of leptin in breast cancer. European Journal of Gynaecological Oncology. 2004. 25(2);192-194.
[1] Mantzoros Ch.S.: "T he role of leptin In human obesity and disease: A review of current evidence". Ann. Intern. Med., 1999,130, 671.
[2] Wiesner G., Vaz M.,C ollier G. et al.: "Lcptin is related from the human brain: Influence of adiposity and gender". J. Clin. Endocrinol. Metab., 1999, 84, 2270.
[3] Sierra-Honigmann M.R., Nath A.K.. Murakami C. et al.: "B10-logical action of leptin as an angiogcnic factor". Science, 1998. 81, 1683.
[4] Baumann H., Morella K.K, White D.W. et al.:'The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptor". Proc. Natl. Acad. Sci. USA , 1996, 93, 8374.
[5] Ihle J.N., Stats: "Signal transducers and activators of transcription". Cell., 1996, 84, 331.
[6] Mantzoros C.S., Bolhke K., Moschos S.. Cramer D.W.: "Lcptin in relation to carcinoma in situ of the breast: a study of premenopausal cases control". Int. J. Cancer, 1999, 80 (4), 523.
[7] Caro J.F., Kolaczynski J.V., Nyce M.R. et al.: "Decreased carebrospinal-fluid, serum leptin ratio in obesity: a possible mechanism for leptin resistance". Lancet, 1996, 348, 159.
[8] Considine R.U., Siha M.K., H eiman M.L. et al.:''Serum immunoreactive-leptin concentration in normal-weight and obese humans". N. EnJ?I. J. Med., 1996, 334, 292.
[9] Strobel A.,l ssad T.,C amoin L. et al: “A leptin missense mutation associated with hypogonadism and morbid obesity''. Nat. Genet., 1998, 18, 213.
[10] Clement K., Garner C., Hager J. et al.: "Indication for linkage of the human OB gene region with extreme obesity". Diabetes, 1996, 45, 687.
[11] Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy U. et al "Leptin mediates a proliferative response in human MCF 7 breast cancer cells". Bioch. Biophys. Res. Comm., 2002, 293 (1), 622.
[12] Laud K., Gourdou J., Pessemesse L. et al.: "Indentification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line". Mo/. Cell. Enclocrinol., 2002, 188, (1-2), 219.
[13] Hu X., Juneja S.C, Maihle N.J., Cleary M.P.: "Leptin - a growth factor in normal mammary gland development". J. Natl. Cancer Inst., 2002, 94 (22), 1704.
[14] O'Brien S.N., Welter B.H., Price T.M., Clemson S.G.: "Presence of leptin in breast cell lines and breast tumors". Biochem. Biophys. Res. Comm., 1999, 259, 695.
[15] Peyrat J.P., Bonneterre J., Hecquet B. et al.: "Plasma insulin-like growth factor-I (IGF-1) concentrations in human breast cancer". Ew: J. Cancer, 1993, 29A, 492.
[16] Bohlke K., Cramer D.W., Trichopolus D., Mantzaros C.S.: "Insulin-like growth factor-I relation to premenopausal ductal carcinoma in situ of the breast". Epidemiology, I 998, 9, 570.
[17] Bruning P.F., Van Doorn J., Bonfrer J.M. et al.: "Insulin-like growth-factor-binding protein 3 is decreased in early stage operable pre-menopausal breast cancer" . Int. J. Cancer, 1995, 62, 266.
[18] Petriodou E., Papadimanti、Y., Markopulos C.H. et ell.: "Leptin and insulin-like growth factor-I in relation to breast cancer (Greece)". Cancer Caus. Contr., 2002, 11, 383.
[19] Ozet A., Arpaci F., Yilmaz M.I. et ell.: "Effects of tamoxifen on the serum leptin level in patients with breast cancer". Jpn. J. Clin Oncol., 2001, 31 (9), 424.
[20] Tessitore L., Vizio B., Jenkin、0. et ed.: "Leptin expression in colorectal and breast cancer patients". Int. J. Mo/. Med., 2000, 5, 421.
[21] Christensen D.: "Leptin links diet to breast cancer". 10.IV.2003 http.bmn.com/news/stoni/day=03041.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top